Compare IDEXX Laboratories, Inc. (IDXX) vs Global X Lithium & Battery Tech ETF (LIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Global X Lithium & Battery Tech ETF — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Global X Lithium & Battery Tech ETF trades at $69.73 (market cap $1.45B). The key difference: IDEXX Laboratories, Inc. is far larger — about 27.9× Global X Lithium & Battery Tech ETF's market cap, and Global X Lithium & Battery Tech ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Global X Lithium & Battery Tech ETF for 56 Days on average.
| IDXX | LIT | |
|---|---|---|
Market Cap | $40.43B | $1.45B |
Volume | 692,164 | 89,392 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $766.68 | $91.62 |
52-Week Low | $504.70 | $53.92 |
Typical Hold Time | 46 Days | 56 Days |
Enterprise Value | $41.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
LIT (Global X Lithium & Battery Tech ETF) trades at $69.02, down 0.7% on the day, with mixed technical signals showing a bullish overall trend but bearish moving averages and oscillators. The ETF's recent performance reflects ongoing volatility in lithium markets, with short interest dropping 53.1% in September 2026. Recent news highlights continued growth in electric vehicle adoption and China's ambitious 30% NEV fleet target by 2030, supporting long-term battery technology demand.
The ETF presents exposure to the growing battery technology sector with strong catalysts from EV adoption and energy storage markets. However, investors face risks from lithium price volatility, Chinese export controls on critical minerals, and geopolitical trade tensions that could impact supply chains and performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →
